The healthcare sector, particularly pharmaceuticals and hospitals, have demonstrated strong performance in the March 2025 quarter, with revenue growth exceeding that of Nifty 500 companies. Even though the pharmaceutical segment faces challenges in the short-run, due to potential US tariffs and other factors, long-term prospects remain positive. There has been growth in the hospital sector as well, fueled by rising lifestyle diseases and increased healthcare accessibility.